June Halper

4.4k total citations · 5 hit papers
71 papers, 3.1k citations indexed

About

June Halper is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, June Halper has authored 71 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pathology and Forensic Medicine, 15 papers in Neurology and 13 papers in Oncology. Recurrent topics in June Halper's work include Multiple Sclerosis Research Studies (48 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (12 papers). June Halper is often cited by papers focused on Multiple Sclerosis Research Studies (48 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (12 papers). June Halper collaborates with scholars based in United States, Canada and Switzerland. June Halper's co-authors include Fred Lublin, Gerald Garmany, William Likosky, Douglas S. Goodin, W. H. Stuart, Stanley van den Noort, D. H. Silberberg, Kathleen Costello, John DeLuca and Nicholas G. LaRocca and has published in prestigious journals such as Neurology, Archives of Physical Medicine and Rehabilitation and Journal of the Neurological Sciences.

In The Last Decade

June Halper

68 papers receiving 3.0k citations

Hit Papers

Disease modifying therapi... 2002 2026 2010 2018 2002 2018 2018 2020 2021 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
June Halper 2.6k 855 485 441 342 71 3.1k
Elaine Kingwell 2.6k 1.0× 656 0.8× 470 1.0× 670 1.5× 240 0.7× 80 3.3k
John R. Corboy 2.3k 0.9× 1.1k 1.3× 527 1.1× 628 1.4× 231 0.7× 110 3.9k
Raed Alroughani 1.5k 0.6× 483 0.6× 335 0.7× 334 0.8× 326 1.0× 166 2.2k
Sarah A. Morrow 2.4k 0.9× 857 1.0× 237 0.5× 419 1.0× 393 1.1× 140 3.5k
Denise I. Campagnolo 2.3k 0.9× 586 0.7× 561 1.2× 467 1.1× 317 0.9× 80 4.0k
Claudio Gobbi 2.0k 0.8× 1.2k 1.4× 453 0.9× 457 1.0× 417 1.2× 158 3.7k
E. Ann Yeh 2.1k 0.8× 1.4k 1.7× 344 0.7× 464 1.1× 168 0.5× 163 3.4k
Jonathan Goldstein 1.6k 0.6× 1.3k 1.5× 433 0.9× 564 1.3× 207 0.6× 44 2.8k
Jelena Drulović 3.2k 1.3× 1.2k 1.4× 432 0.9× 929 2.1× 407 1.2× 174 4.7k
Tuula Tyry 2.8k 1.1× 487 0.6× 269 0.6× 468 1.1× 520 1.5× 83 3.7k

Countries citing papers authored by June Halper

Since Specialization
Citations

This map shows the geographic impact of June Halper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June Halper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June Halper more than expected).

Fields of papers citing papers by June Halper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June Halper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June Halper. The network helps show where June Halper may publish in the future.

Co-authorship network of co-authors of June Halper

This figure shows the co-authorship network connecting the top 25 collaborators of June Halper. A scholar is included among the top collaborators of June Halper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June Halper. June Halper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bogaardt, Hans, Daniel Golan, Stacie Attrill, et al.. (2023). Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?. Multiple Sclerosis and Related Disorders. 73. 104630–104630. 10 indexed citations
3.
Hersh, Carrie M., et al.. (2023). Diversity, Equity, and Inclusion in the Multiple Sclerosis Community: A Call to Action. International Journal of MS Care. 25(5). 199–205. 4 indexed citations
4.
Newsome, Scott D., et al.. (2023). No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]. Neurology and Therapy. 12(6). 1909–1935. 17 indexed citations
5.
Newsome, Scott D., Anne H. Cross, Robert J. Fox, et al.. (2021). COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America. Neurology Neuroimmunology & Neuroinflammation. 8(5). 12 indexed citations
7.
Salter, Amber, June Halper, Bruce F. Bebo, et al.. (2020). Covims registry: clinical characterization of SARS-COV-2 infected multiple sclerosis patients in north america. Multiple Sclerosis Journal. 26. 97–97. 3 indexed citations
8.
Rae‐Grant, Alexander, Gregory S. Day, Ruth Ann Marrie, et al.. (2018). Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology. 90(17). 777–788. 395 indexed citations breakdown →
9.
Foley, Frederick W., et al.. (2012). Depression Levels and Interferon Treatment in People with Multiple Sclerosis. International Journal of MS Care. 14(1). 10–16. 18 indexed citations
10.
Cook, Stuart D., Suhayl Dhib‐Jalbut, Peter C. Dowling, et al.. (2012). Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course. International Journal of MS Care. 14(3). 105–114. 14 indexed citations
11.
Cadavid, Diego, Leo Wolansky, Joan Skurnick, et al.. (2009). Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology. 72(23). 1976–1983. 132 indexed citations
12.
DiLorenzo, Terry A., et al.. (2008). A qualitative investigation of adaptation in older individuals with multiple sclerosis. Disability and Rehabilitation. 30(15). 1088–1097. 32 indexed citations
13.
Kalmar, Jessica H., Elizabeth A. Gaudino, Nancy B. Moore, June Halper, & John DeLuca. (2008). The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.. Neuropsychology. 22(4). 442–449. 124 indexed citations
14.
Halper, June. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences. 256. S34–S38. 52 indexed citations
15.
Goverover, Yael, Jessica H. Kalmar, Marla A. Shawaryn, et al.. (2005). The Relation Between Subjective and Objective Measures of Everyday Life Activities in Persons With Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation. 86(12). 2303–2308. 70 indexed citations
16.
DiLorenzo, Terry A., June Halper, & Mary Ann Picone. (2003). Reliability and validity of the Multiple Sclerosis Quality of Life Inventory in older individuals. Disability and Rehabilitation. 25(16). 891–897. 30 indexed citations
17.
Halper, June, et al.. (2003). Rethinking Cognitive Function in Multiple Sclerosis: A Nursing Perspective. Journal of Neuroscience Nursing. 35(2). 70–81. 15 indexed citations
18.
Coyle, Patricia K. & June Halper. (2001). Meeting the challenge of progressive multiple sclerosis. 2 indexed citations
19.
Holland, Nancy J., June Halper, Rosalind Kalb, et al.. (2001). Adherence to Disease-Modifying Therapy in Multiple Sclerosis: Part I. Rehabilitation Nursing. 26(5). 172–176. 22 indexed citations
20.
Shnek, Zachary M., Frederick W. Foley, Nicholas G. LaRocca, et al.. (1997). Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Annals of Behavioral Medicine. 19(3). 287–294. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026